click below
click below
Normal Size Small Size show me how
IOS 11 Exam 1
Treatment of Invasive Fungal Infections 2
| Question | Answer |
|---|---|
| C.albicans charactericstics | Most pathofenic via the ability adhere to host tissue and transform from yeast to hyphal phase |
| Risks for C, albican infections | Preganancy, age, trauma, hematologic, endocrine, (DM, TSH), iatrigenic (steroid, chemotherapy, immunosuppressant, IVDA, malnutrution |
| Non-hematogenous types of C. albican infections | Superficial (oral, vaginal) Deepseated(Esophageal, cystitis, peritonitis) |
| Hematogenous types of C. albican infections | Candidiasis, Sndophthalmitis, osteomyelitis, infectious endocarditis, pyelonephritis, pulmonary, meningitis |
| Asperigillus Characterisitics | Found in the soil, water, or near decaying vegetation |
| Risk factors for getting asperigillus infection | Bone marrow transplant, hematologic disease, solid organ transplant, AIDS |
| Types of Aspergillus | Invasive, pulmonary, and allerfic bronchopulmonary aspergillosis |
| Dimorphic fungi | Sporotrichosis, Blastomycosis, Coccidiodes, Histoplasmosis |
| Amphotericin B spectrum of activity | Candida spp (not lusitaniae), cryptococcus neoformans, Diphormorphic Blastomyces, Coccidiodes, Histoplasma, Molds-Aspergillus, Fusarium, Sporothris schenckii |
| Flucytosine Spectrium of activity is | Candida spp, Cryptococcus neoformans, Saccharomyces cerevisiaw, Chromoycosis-off label use |
| Fluconazole spectrum of activity | Yeast-Cryptococcus neoformans, C. albicans, C. tropicalis, C. parapsilosis- Dimorphic fungi-Histoplasma Blastomyces, Coccidides |
| Itraconazole Spectrum of Activity | Yeast- Candida spp, Cryptococcus neoforms -Dimorphic fungi-Blastomyces, Histoplasma, Coccidiodes, Paracoccidodes, Paracoccidiodes brasilliensis and Filentous fungi- Asperigillus spp, Zygomycetes, Sporothrix |
| Voriconazole contraindications | Absolute-Terfenadine, Astemizole, Cisapride, Pimozide, Quinidine, Ergot alkaloids, Long acting barbiturates, sirolimus, pregnancy D |
| Biofilms of Candidas can be treated with | Caspofungin, Abelcet, Ambisome and Posaconazole |
| Empirical Treatment of Candidiasis | Caspofungin IV 70mg Load x1 then 50mg IV q24hr, or Ambisome 5mg/kg IV Q24hr or AMB 0.5-1mg/kg IV QD if normal renal function |
| Candidiasis germ positive tube treatment | FLuconazole IV/PO 6-12mg/kg/day which is about 400-800mg |
| Treatment of Candida Endocarditis or endovascular or prosthetic material | Caspofungin 70mg x1 and 50mg IV QD or Ambisone 5mg/kg/day |
| Dx of invasive Aspergillosis/Pulmonary disease | Histoplatholic evidence of acute-angle branching, septated non-pigmented hyphe measuring 2-4um or radiographic with pleural densities,or CT with halo (edema or bleeding) or + sputum |
| Treatment of invasive Aspergillosis | IV voriconazole 6mg/kg Q12 hr x 2 doses then 4mg/kg IV q12hr only if CrCl>30ml/min accumulation of cyclodextran, if <30 PO voriconazole 400BID or Abelcet or ambisome |
| Symptoms of Non-HIV cryptococcus neoformans-Pulminary and non-CNS | Cough, pneimonitis, fever, sputum production, pleura symptoms |
| Treatment for Pulmonary & Non-CNS Cryptococcus neoformans | Asymptomatic Immunocompetent patientFluconazole 400mg QD for 3-6months, For Symptomatic patient 6-12 months of Fluconazole 400mg QD |
| Cryptococcus Neoformans with CNS component (NON-HIV) | Ambisone + Flucytosine 100mg/kg/day 2 weeks then Fluconazole 400mg /day for 10 weeks then maintenance of Fluconazole 200-400mg PO QD for 8-10weeks if immunosuppressed 6-12 months and fluconasole 400-800mg*** |
| Goal of Treating Cryptococcus neoformans CNS disease | Cure the infection (CSF steriliazition) and prevntion of long-term CNS system sequele, such as cranial nerve palsies, hearing loss, and blindness |
| AIDS related Crytococcal Disease-Pulmonary and Meningitis | Pulmonary- Fluconazole 200-400mg/d FOR LIFE CNS induction -Ambisome+Flucytosine 100mg/kg/day 2weeks, then Fluconasole 400mg for 10weeks then Fluconazole 200-400 FOR LIFE |
| Renal dysfunction patients | Do not used Abelcet unless Mucormycosis, Do not us IV voriconazole if CrCl <30 |
| Hepatic dysfunction remember | Casopfungin in moderate liver impariment 50mg IV to 30mg IV for maintenance therapy |
| Caspofungin DI | Cyclosporin |
| Caspofungin and Ambisome are better than azoles for infections for | Biofilms |